Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin rebounds to $65,000 as long-term and short-term holders sell on the rally

Bitcoin rebounds to $65,000 as long-term and short-term holders sell on the rally

AiCoinAiCoin2026/07/16 16:12
Show original
According to CoinDesk, the U.S. Consumer Price Index (CPI) rose 3.5% year-on-year in June, lower than the expected 3.8%. Bitcoin’s price rebounded to nearly $65,000. On-chain data shows that long-term holders (holding for over 5 months) reduced their positions at a loss, while short-term holders took profits at a pace of over $4 million per day. Analysts pointed out that this simultaneous selling created supply pressure above as the market attempted a breakout. Some observers questioned the sustainability of the rebound, believing that the June CPI cooldown was mainly driven by declining gasoline prices, and that the recent rebound in oil prices has reduced the reference value of the data.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46